Biotinylated hepta-, nona- and undeca-α-(1 → 3)-d-glucosides representing long oligosaccharides of α-(1 → 3)-d-glucan, one of the major components of the cell walls of the fungal pathogen Aspergillus fumigatus, were synthesized for the first time via a blockwise strategy. Convergent assembly of the α-(1 → 3)-d-glucan chains was achieved by glycosylation with oligoglucoside derivatives bearing 6- O-benzoyl groups. Those groups are capable of remote α-stereocontrolling participation, making them efficient α-directing tools even in the case of large glycosyl donors. Synthetic biotinylated oligoglucosides (and biotinylated derivatives of previously synthesized tri- and penta-α-(1 → 3)-d-glucosides) loaded on streptavidin microtiter plates were shown to be better recognized by anti-α-(1 → 3)-glucan human polyclonal antibodies and to induce higher cytokine responses upon stimulation of human peripheral blood mononuclear cells than their natural counterpart, α-(1 → 3)-d-glucan, immobilized on a conventional microtiter plate. Attachment of the synthetic oligosaccharides equipped with a hydrophilic spacer via the streptavidin-biotin pair allows better spatial presentation and control of the loading compared to the random sorption of natural α-(1 → 3)-glucan. Increase of oligoglucoside length results in their better recognition and enhancement of cytokine production. Thus, using synthetic α-(1 → 3)-glucan oligosaccharides, we developed an assay for the host immune response that is more sensitive than the assay based on native α-(1 → 3)-glucan.
Biotinylated n class="Chemical">hepta-, nona- and undeca-α-(1 → 3)-d-glucosides representing long oligosaccharides of α-(1 → 3)-d-glucan, one of the major components of the cell walls of the fungal pathogen Aspergillus fumigatus, were synthesized for the first time via a blockwise strategy. Convergent assembly of the α-(1 → 3)-d-glucan chains was achieved by glycosylation with oligoglucoside derivatives bearing 6- O-benzoyl groups. Those groups are capable of remote α-stereocontrolling participation, making them efficient α-directing tools even in the case of large glycosyl donors. Synthetic biotinylated oligoglucosides (and biotinylated derivatives of previously synthesized tri- and penta-α-(1 → 3)-d-glucosides) loaded on streptavidin microtiter plates were shown to be better recognized by anti-α-(1 → 3)-glucanhuman polyclonal antibodies and to induce higher cytokine responses upon stimulation of human peripheral blood mononuclear cells than their natural counterpart, α-(1 → 3)-d-glucan, immobilized on a conventional microtiter plate. Attachment of the synthetic oligosaccharides equipped with a hydrophilic spacer via the streptavidin-biotin pair allows better spatial presentation and control of the loading compared to the random sorption of natural α-(1 → 3)-glucan. Increase of oligoglucoside length results in their better recognition and enhancement of cytokine production. Thus, using synthetic α-(1 → 3)-glucanoligosaccharides, we developed an assay for the host immune response that is more sensitive than the assay based on native α-(1 → 3)-glucan.
Authors: Yury E Tsvetkov; Monika Burg-Roderfeld; Gabriele Loers; Ana Ardá; Elena V Sukhova; Elena A Khatuntseva; Alexey A Grachev; Alexander O Chizhov; Hans-Christian Siebert; Melitta Schachner; Jesús Jiménez-Barbero; Nikolay E Nifantiev Journal: J Am Chem Soc Date: 2011-12-19 Impact factor: 15.419
Authors: Bozhena S Komarova; Alexey G Gerbst; Anastasiia M Finogenova; Andrey S Dmitrenok; Yury E Tsvetkov; Nikolay E Nifantiev Journal: J Org Chem Date: 2017-08-15 Impact factor: 4.354
Authors: Gordon D Brown; Jurgen Herre; David L Williams; Janet A Willment; Andrew S J Marshall; Siamon Gordon Journal: J Exp Med Date: 2003-04-28 Impact factor: 14.307
Authors: Benjamin N Gantner; Randi M Simmons; Scott J Canavera; Shizuo Akira; David M Underhill Journal: J Exp Med Date: 2003-04-28 Impact factor: 14.307
Authors: Andrey L Matveev; Vadim B Krylov; Ljudmila A Emelyanova; Arsenii S Solovev; Yana A Khlusevich; Ivan K Baykov; Thierry Fontaine; Jean-Paul Latgé; Nina V Tikunova; Nikolay E Nifantiev Journal: PLoS One Date: 2018-03-08 Impact factor: 3.240
Authors: Ingrida Vendele; Janet A Willment; Lisete M Silva; Angelina S Palma; Wengang Chai; Yan Liu; Ten Feizi; Maria Spyrou; Mark H T Stappers; Gordon D Brown; Neil A R Gow Journal: PLoS Pathog Date: 2020-01-30 Impact factor: 6.823
Authors: Sarah Sze Wah Wong; Vadim B Krylov; Dmitry A Argunov; Alexander A Karelin; Jean-Phillipe Bouchara; Thierry Fontaine; Jean-Paul Latgé; Nikolay E Nifantiev Journal: mSphere Date: 2020-01-08 Impact factor: 4.389
Authors: Ekaterina A Kurbatova; Nelli K Akhmatova; Anton E Zaytsev; Elina A Akhmatova; Nadezhda B Egorova; Natalya E Yastrebova; Elena V Sukhova; Dmitriy V Yashunsky; Yury E Tsvetkov; Nikolay E Nifantiev Journal: Front Immunol Date: 2020-12-04 Impact factor: 7.561
Authors: Ema Paulovičová; Lucia Paulovičová; Pavol Farkaš; Alexander A Karelin; Yury E Tsvetkov; Vadim B Krylov; Nikolay E Nifantiev Journal: Front Cell Infect Microbiol Date: 2019-11-08 Impact factor: 5.293
Authors: Vadim B Krylov; Arsenii S Solovev; Ilya A Puchkin; Dmitry V Yashunsky; Anna V Antonets; Olga Y Kutsevalova; Nikolay E Nifantiev Journal: J Fungi (Basel) Date: 2021-06-24
Authors: D V Yashunsky; V S Dorokhova; B S Komarova; E Paulovičová; V B Krylov; N E Nifantiev Journal: Russ Chem Bull Date: 2022-01-15 Impact factor: 1.222